Science News
from research organizations

Hope for more options in couples where one partner is HIV positive

Date:
November 28, 2011
Source:
Public Library of Science
Summary:
In sub-Saharan Africa, couples in long-term relationships where one partner is HIV-positive and the other is HIV-negative could benefit from anti-AIDS drugs given either as treatment or as a prevention measure to reduce the risk of HIV transmission.
Share:
       
FULL STORY

In sub-Saharan Africa, couples in long-term relationships where one partner is HIV-positive and the other is HIV-negative (HIV serodiscordant couples) could benefit from anti-AIDS drugs (antiretroviral therapy) given either as treatment or as a prevention measure (prophylaxis) to reduce the risk of HIV transmission. These findings, from a modelling study led by Timothy Hallett from Imperial College London and published in this week's PLoS Medicine, also show that this strategy could be cost-effective.

In sub-Saharan Africa, where most new HIV infections occur and condom use is often low, 10-20% of stable partnerships are serodiscordant. The authors used detailed information and specific data from South Africa to construct a model to simulate HIV infection and disease progression among hypothetical HIV serodiscordant couples in stable heterosexual relationships. The authors used the model to compare the impact on HIV transmission, survival and quality of life and the cost-effectiveness of different prophylaxis strategies.

To keep couples alive without the HIV-uninfected partner becoming infected, the authors found that it could be at least as cost-effective to provide prophylaxis to the uninfected partner as to initiate antiretroviral therapy earlier than current guidelines in the infected partner. Specifically, the most cost-effective strategy for couples could be to use prophylaxis in the uninfected partner prior to starting antiretroviral therapy in the infected partner.

These findings suggest that prophylaxis may become a valuable addition, in some settings, to existing approaches for HIV prevention such as condom promotion, male circumcision programs and anti-retroviral treatment.

The authors say: "We hope [these findings] might inform the choices that will be available for HIV prevention in couples. We note, however, that it is important that many other considerations besides cost effectiveness should inform decision-making for HIV treatment initiation and provision of [prophylaxis] in couples, including equitable access and the preferences of the couples themselves."


Story Source:

The above post is reprinted from materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Timothy B. Hallett, Jared M. Baeten, Renee Heffron, Ruanne Barnabas, Guy de Bruyn, Íde Cremin, Sinead Delany, Geoffrey P. Garnett, Glenda Gray, Leigh Johnson, James Mcintyre, Helen Rees, Connie Celum. Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study. PLoS Medicine, 2011; 8 (11): e1001123 DOI: 10.1371/journal.pmed.1001123

Cite This Page:

Public Library of Science. "Hope for more options in couples where one partner is HIV positive." ScienceDaily. ScienceDaily, 28 November 2011. <www.sciencedaily.com/releases/2011/11/111115175629.htm>.
Public Library of Science. (2011, November 28). Hope for more options in couples where one partner is HIV positive. ScienceDaily. Retrieved September 5, 2015 from www.sciencedaily.com/releases/2011/11/111115175629.htm
Public Library of Science. "Hope for more options in couples where one partner is HIV positive." ScienceDaily. www.sciencedaily.com/releases/2011/11/111115175629.htm (accessed September 5, 2015).

Share This Page: